Funder directory / Switzerland / Venture capital firms
Pureos Bioventures
Pureos Bioventures invests venture capital in private innovative drug development companies. The firm focuses on supporting the next generation of biological drugs and novel drug formats to treat severe diseases.
StagesNot stated
Deals recorded21
What they invest in
All investments and operations
21 operations| Company | Round | Amount | Date | Co-investors | Source |
|---|---|---|---|---|---|
| Acrivon Therapeutics | – | – | – | – | Portfolio page |
| Adcytherix | – | – | – | – | Portfolio page |
| Alentis Therapeutics | – | – | – | – | Portfolio page |
| AnaCardio | – | – | – | – | Portfolio page |
| Araris Biotech | – | – | – | – | Portfolio page |
| BaseLaunch CH | – | – | – | – | Portfolio page |
| Callio Therapeutics | – | – | – | – | Portfolio page |
| Citryll | – | – | – | – | Portfolio page |
| Corlieve Therapeutics FR | – | – | – | – | Portfolio page |
| Engimmune Therapeutics | – | – | – | – | Portfolio page |
Show all 21 operations
Exits
- Araris Biotech Acquired by Taiho Pharmaceutical2025 · Source
- ImCheck Therapeutics Acquired by Ipsen2025 · Source
- Acrivon Therapeutics IPO2022 · Source
- Corlieve Therapeutics Acquired by uniQure2021 · Source
Shown only when an exit is documented by a public source.
Similar funders
- ACE Ventures · Venture capital, Switzerland
- Alpana Ventures · Venture capital, Switzerland
- Arcanys Ventures · Venture capital, Switzerland
- b2venture · Venture capital, Switzerland
- BioMedPartners · Venture capital, Switzerland
- BlueOcean Ventures · Venture capital, Switzerland